Revised TargetsCowen and Co. analyst Joshua Jennings raised his target for Mississauga-based Profound Medical Corp. to US$28 from US$22 with an “outperform” rating, while Jefferies’ Raj Denhoy cut his target to US$30 from US$38 with a “buy” rating. The current average is US$26.05.